Projected Income Statement: Redcare Pharmacy NV

Forecast Balance Sheet: Redcare Pharmacy NV

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 36 -90 -11 188 161 184 193 181
Change - -350% -112.22% 1,609.09% -14.36% 14.51% 4.89% -6.22%
Announcement Date 3/17/20 3/3/21 3/2/22 3/7/23 3/5/24 - - -
1EUR in Million
Estimates

Cash Flow Forecast: Redcare Pharmacy NV

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
CAPEX 1 14.74 53.34 43.16 53.52 38.22 59.24 61.6 76.22
Change - 261.79% -19.08% 24.02% -28.59% 55.01% 3.98% 23.74%
Free Cash Flow (FCF) 1 -45.11 -35.53 -31.52 -82.64 23.24 -28.44 -12.54 53.48
Change - -21.23% -11.28% 162.14% -128.12% -222.4% -55.91% -526.44%
Announcement Date 3/17/20 3/3/21 3/2/22 3/7/23 3/5/24 - - -
1EUR in Million
Estimates

Forecast Financial Ratios: Redcare Pharmacy NV

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026

Profitability

        
EBITDA Margin (%) -1.94% 2.23% -0.47% -0.67% 2.97% 1.63% 2.66% 4.12%
EBIT Margin (%) -4.02% 0.57% -3.05% -3.95% -0.21% -1.29% -0.85% 0.44%
EBT Margin (%) -6.02% -1.65% -7.35% -6.98% -0.8% -1.71% -0.31% 1.89%
Net margin (%) -5.17% -1.73% -7% -6.45% -0.67% -1.65% -0.55% 1.36%
FCF margin (%) -6.43% -3.67% -2.97% -6.86% 1.29% -1.2% -0.42% 1.5%
FCF / Net Income (%) 124.37% 211.87% 42.49% 106.43% -192.97% 72.58% 76.35% 110.13%

Profitability

        
ROA -9.33% -3.5% -11.24% -10.27% -1.38% -3.74% -5.65% 4.15%
ROE -16.24% -5.1% -17.65% -20.17% -2.75% -6.57% -1.39% 7.59%

Financial Health

        
Leverage (Debt/EBITDA) -2.65x - - -23.42x 3x 4.73x 2.45x 1.23x
Debt / Free cash flow -0.8x - - -2.28x 6.92x -6.46x -15.42x 3.38x

Capital Intensity

        
CAPEX / Current Assets (%) 2.1% 5.51% 4.07% 4.44% 2.12% 2.49% 2.08% 2.13%
CAPEX / EBITDA (%) -108.62% 246.69% -863.18% -665.39% 71.45% 152.61% 78.1% 51.71%
CAPEX / FCF (%) -32.68% -150.1% -136.91% -64.77% 164.5% -208.32% -491.25% 142.54%

Items per share

        
Cash flow per share 1 -2.324 1.24 0.6506 -1.619 3.194 0.4129 2.431 6.09
Change - -153.35% -47.53% -348.8% -297.34% -87.07% 488.67% 150.51%
Dividend per Share 1 - - - - - - - -
Change - - - - - - - -
Book Value Per Share 1 17.82 21.46 22.96 19.49 25.85 25.76 25.24 27.29
Change - 20.45% 6.98% -15.12% 32.64% -0.33% -2.03% 8.13%
EPS 1 -2.78 -1.17 -4.15 -4.32 -0.73 -1.956 -0.8338 2.244
Change - -57.91% 254.7% 4.1% -83.1% 167.97% -57.37% -369.06%
Nbr of stocks (in thousands) 13,464 17,935 18,095 18,095 18,199 20,342 20,342 20,342
Announcement Date 3/17/20 3/3/21 3/2/22 3/7/23 3/5/24 - - -
1EUR
Estimates
2024 *2025 *
P/E ratio -60.5x -142x
PBR 4.6x 4.69x
EV / Sales 1.09x 0.88x
Yield - -
More valuation ratios * Estimated data

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Trading Rating
Investor Rating
ESG MSCI
AAA
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
12
Last Close Price
118.40EUR
Average target price
159.25EUR
Spread / Average Target
+34.50%
Consensus

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Equities
  3. RDC Stock
  4. Financials Redcare Pharmacy NV